Sunday, November 22nd, 2009

Resource Stock Roundup Wednesday August 27, 2008

Aug 27th, 2008 | By Doug Casey | Category: Financial News, Gold Market

The resource rich Canadian markets essentially flatlined during Tuesday trading as bank earnings took centre stage.

For the tale of the tape, the TSX Exchange tacked on 0.08%, while the TSX Gold Index climbed 0.3% and the TSX Venture Exchange, Canada’s largest junior exploration bourse, added 0.13% with the declining issuers beating out the advancers by a 475 to 349 margin on volume of 101 million shares traded.

Mining giant Rio Tinto showed that the diversified miners are not dead yet. The major tabled earnings of $6.9 billion in the first six months of the year. This marks a 113% jump over the same period of 2007 and should help the company fend off a $147 billion takeover offer from rival BHP Billiton. Rio ended the day up $1.60 to $381.25 in New York.

Investors digested yesterday’s news that Hathor Exploration intersected 5.3 metres of basement-hosted uranium mineralization having off-scale radioactivity readings at its 90% owned Midwest NorthEast property in Saskatchewan and decided to belatedly reward the stock. Hathor ended the day up C$0.23 at C$3.58, while 10% owner Terra Ventures added C$0.07 to close at C$0.90.

Rubicon Minerals tagged another nice hole at its Phoenix project in the Red Lake mining camp of Ontario. The hot hole yielded 891.1 grams gold per tonne over 2 metres and as a result Rubicon ended the day up C$0.35 at C$1.71.

Management of Petaquilla Copper finally gave in to the revised C$2.20 per share cash offer by Inmet Mining. Petaquilla added C$0.29 to close at C$2.18.

Early indication from the Canadian financial earnings front is that more bad news is pending and that means more lack of liquidity, which could be good news for the gold bugs. We will see what Wednesday trading has in store.

Source: Resource Stock Roundup Wednesday August 27, 2008


AdvertisementOn March 30th, FDA results could make you $195,600

On March 30th, there'll be an announcement of FDA results for a new drug that could become the bestselling pill in the history of medicine.

One medical source says, "It could tap the largest pharmaceutical market ever." Even more exciting, early investors could make as much as $195,600, overnight... by getting in immediately.

Click here for the full details.



Tags: , , , , , , ,

By Doug Casey

Related Articles



About the Author

Doug CaseyDoug Casey is a contrarian investor, sought-after public speaker and author of several books. His work "Crisis Investing" held the position of # 1 bestseller on the New York Times list for 26 consecutive weeks. Doug's unusual views on the economy - and just about everything else - have gained a huge following in the investment community, and it certainly helps that his stock recommendations of undervalued junior exploration companies have made his subscribers millions. Now in its 27th year, Doug's monthly newsletter, the International Speculator, is one of the most established and esteemed publications on gold, silver and other natural resource investments. Together with the Casey Energy Speculator, it covers a broad range of carefully selected stocks with the very real potential of double- and triple-digit returns within 12 to 24 months.

See All Posts by This Author

Casey Research

The Daily Resource PLUS was designed from the start to be the world's most comprehensive yet quick-reading daily e-letter providing concise updates on precious metals, energy, resource stocks, currencies, unfolding economic trends and more... including private placement financings!

See All Posts from This Publication

Leave Comment